Communications Liaison: Difference between revisions

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
No edit summary
No edit summary
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
Meet our Communications Liaison!
Meet our Communications Liaison!
<br />
<br />
[[File:Marilena Melas - headshot.png|center|thumb|Marilena Melas, PhD, New York Genome Center; Assistant Clinical Lab Director, Molecular Diagnostics; '''[mailto:mmelas@nygenome.org <u>mmelas@nygenome.org</u>]'''; '''Communications Liaison CCGA''']]
[[File:Otsubo_Headshot_2023.JPG|center|thumb|Aiko Otsubo, PhD, Assistant Professor, Department of Pathology, University of Michigan; Lab Director in Cytogenetics and Molecular Genetics Laboratories; '''[mailto:aotsubo@med.umich.edu <u>aotsubo@med.umich.edu</u>]'''; '''Communications Liaison CCGA''']]
<br />
<br />
'''Previous Communications Liaison''''':
Marilena Melas, PhD, Assistant Clinical Lab Director in Molecular Diagnostics, New York Genome Center

Latest revision as of 21:30, 19 February 2023

Meet our Communications Liaison!

Aiko Otsubo, PhD, Assistant Professor, Department of Pathology, University of Michigan; Lab Director in Cytogenetics and Molecular Genetics Laboratories; aotsubo@med.umich.edu; Communications Liaison CCGA


Previous Communications Liaison:

Marilena Melas, PhD, Assistant Clinical Lab Director in Molecular Diagnostics, New York Genome Center